Related Experiment Video
Updated: Oct 23, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Risks and outcomes in community acquired pneumonia
1Dalhousie University, Queen Elizabeth II Health Sciences Centre and Victoria General Hospital, Halifax, Canada. tmarrie@is.dal.ca
Abstract:
Risks and probable outcomes in patients with community acquired pneumonia have always been assessed intuitively by clinicians, but are now being intensively and formally studied. Several risk scoring systems have been developed to assign patients to different risk categories, with respect to important outcomes such as mortality or intensive care unit admission. Predictive factors include demographic characteristics such as age and sex, comorbidities such as neoplastic disease or congestive heart failure, abnormalities on physical examination and abnormal laboratory findings. Prospective use of one such prediction rule found a mortality rate of 0.5% in the lowest risk category, rising to 27.1% in the highest risk group. Formal assessment of risk can assist the clinician in deciding whether to treat a patient at home or in hospital, and can be an important step in developing clinical practice guidelines.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology